Literature DB >> 15569604

The HTLV-I Tax oncoprotein: hyper-tasking at the molecular level.

Diane R Wycuff1, Susan J Marriott.   

Abstract

HTLV-I is a complex retrovirus that encodes a transcriptional activator, Tax, which regulates expression of the viral promoter. Tax has been shown to be both necessary and sufficient to effect immortalization and transformation of cells in culture and tumorigenesis in animal models. Tax exerts its influence through protein-protein interactions with a variety of molecular targets, including transcription factors and cofactors, histone modifying enzymes and post-translational modifying enzymes. Through these interactions, Tax disrupts cellular regulatory cascades and checkpoints designed to control a variety of systems. The result is untimely activation or repression of gene expression, inappropriate protein modifications, incorrect cell cycling, loss of adequate DNA repair capacity, and potential release of the cell from tumor suppression. Whereas for the virus these functions of Tax provide a means for successful completion of its life cycle, for the cell, they result at best in anarchy, and at worst in death of both the cell and the organism of which that cell is a part.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15569604     DOI: 10.2741/1558

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  13 in total

1.  Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR.

Authors:  Min Li; Patrick L Green
Journal:  J Virol Methods       Date:  2007-03-06       Impact factor: 2.014

2.  Human T-cell leukemia virus type 2 antisense viral protein 2 is dispensable for in vitro immortalization but functions to repress early virus replication in vivo.

Authors:  Han Yin; Priya Kannian; Nathan Dissinger; Robyn Haines; Stefan Niewiesk; Patrick L Green
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia.

Authors:  Marcia Bellon; Christophe Nicot
Journal:  Int J Cancer Oncol       Date:  2015-06-02

4.  Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.

Authors:  Li Xie; Patrick L Green
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Human T-cell leukemia virus type 1 expressing nonoverlapping tax and rex genes replicates and immortalizes primary human T lymphocytes but fails to replicate and persist in vivo.

Authors:  Ihab Younis; Brenda Yamamoto; Andrew Phipps; Patrick L Green
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

6.  Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1.

Authors:  Joshua Arnold; Brenda Yamamoto; Min Li; Andrew J Phipps; Ihab Younis; Michael D Lairmore; Patrick L Green
Journal:  Blood       Date:  2006-01-19       Impact factor: 22.113

7.  PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo.

Authors:  Li Xie; Brenda Yamamoto; Abdelali Haoudi; O John Semmes; Patrick L Green
Journal:  Blood       Date:  2005-11-01       Impact factor: 22.113

8.  Human T-cell leukemia virus type 1 oncoprotein tax represses ZNF268 expression through the cAMP-responsive element-binding protein/activating transcription factor pathway.

Authors:  Di Wang; Ming-Xiong Guo; Hai-Ming Hu; Zhou-Zhou Zhao; Hong-Ling Qiu; Huan-Jie Shao; Chen-Gang Zhu; Lu Xue; Yun-Bo Shi; Wen-Xin Li
Journal:  J Biol Chem       Date:  2008-03-28       Impact factor: 5.157

9.  Phosphorylation regulates human T-cell leukemia virus type 1 Rex function.

Authors:  Matthew Kesic; Rami Doueiri; Michael Ward; O John Semmes; Patrick L Green
Journal:  Retrovirology       Date:  2009-11-17       Impact factor: 4.602

10.  The transcription profile of Tax-3 is more similar to Tax-1 than Tax-2: insights into HTLV-3 potential leukemogenic properties.

Authors:  Sébastien A Chevalier; Stéphanie Durand; Arindam Dasgupta; Michael Radonovich; Andrea Cimarelli; John N Brady; Renaud Mahieux; Cynthia A Pise-Masison
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.